These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside]. Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R. Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922 [Abstract] [Full Text] [Related]
24. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure. Dickstein K, Gottlieb S, Fleck E, Kostis J, Levine B, DeKock M, LeJemtel T. J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263 [Abstract] [Full Text] [Related]
25. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. Mitrovic V, Willenbrock R, Miric M, Seferovic P, Spinar J, Dabrowski M, Kiowski W, Marks DS, Alegria E, Dukát A, Lenz K, Arens HA. Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683 [Abstract] [Full Text] [Related]
26. Positive inotropic and vasodilatory actions of saterinone in vivo. Armah BI, Hofferber E, Jacobitz P. Arzneimittelforschung; 1988 Sep; 38(9):1303-9. PubMed ID: 2906247 [Abstract] [Full Text] [Related]
28. Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts. Zimmermann W, Scholz H, Schumacher C, Wenzlaff H, Haverich A. Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):611-8. PubMed ID: 7526225 [Abstract] [Full Text] [Related]
29. Preload-dependent hemodynamic effects of milrinone in moderate heart failure. Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA. Cardiology; 1992 Jun; 80(2):132-42. PubMed ID: 1611632 [Abstract] [Full Text] [Related]
31. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Aronson D, Burger AJ. Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):98-106. PubMed ID: 11333166 [Abstract] [Full Text] [Related]
32. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study. Leier CV, Lima JJ, Meiler SE, Unverferth DV. Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546 [Abstract] [Full Text] [Related]
33. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study. Schofer J, Hobuss M, Aschenberg W, Tews A. Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780 [Abstract] [Full Text] [Related]
37. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study. Sardina M, Warrington SJ, Boyce M, Johnston A, Bianchini C. J Cardiovasc Pharmacol; 1995 Oct; 26 Suppl 4():S80-90. PubMed ID: 8839231 [Abstract] [Full Text] [Related]
39. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N. J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181 [Abstract] [Full Text] [Related]